Phase 1 Advanced Prostate Cancer Clinical Trials
9 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–9 of 9 trials
Recruiting
Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate CancerMetastatic Prostate Cancer
Genentech, Inc.210 enrolled25 locationsNCT05800665
Recruiting
Phase 1
PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.
Advanced Prostate Cancer
M.D. Anderson Cancer Center70 enrolled1 locationNCT06369246
Recruiting
Phase 1
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma46 enrolled1 locationNCT06130995
Recruiting
Phase 1
A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer
Advanced Prostate Cancer
Janssen Research & Development, LLC250 enrolled6 locationsNCT06095089
Recruiting
Phase 1
Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer
Advanced Prostate Cancer
Hansoh BioMedical R&D Company63 enrolled1 locationNCT07115446
Recruiting
Phase 1Phase 2
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
Malignant Neoplasm of ProstateLocally Advanced Prostate Cancer
Angela Y. Jia, MD PhD45 enrolled1 locationNCT06574880
Recruiting
Phase 1
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma
Brigham and Women's Hospital30 enrolled2 locationsNCT06062745
Recruiting
Phase 1
HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
Advanced Breast CancerAdvanced Prostate CancerTNBC+3 more
Jiangsu Hansoh Pharmaceutical Co., Ltd.157 enrolled1 locationNCT06769425
Recruiting
Phase 1
Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Advanced Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.100 enrolled1 locationNCT05942001